久久网站免费,国产精品高,亚洲国产午夜,黄色免费av网站,亚洲精品九九,999久久久久,天堂福利

Recently, C&D Emerging Industry Equity Investment has received several industry awards. It was ranked NO. 3 on the “2025 Top 100 Industrial Investors” list released by FOF Weekly, and was named one of the “Top 50 Best Corporate Venture Investors in China for 2024” by CVINFO. In addition, several of its portfolio companies—including Impact Therapeutics, Pins Medical, Aidite, Narwal Robotics, SJ SEMI, Kaida Hengye, and AMiner—also received multiple awards on the CVINFO list. In addition, in the “2024 China Best Institutional LP List” released by Chulei Research Institute, C&D Emerging Industry Equity Investment was recognized as one of the “Top 20 Best Institutional LPs in China for 2024” and “Top 10 Best Direct Investment LPs in China for 2024.”

C&D Emerging Industry Equity Investment will remain committed to the mission of "exploring new values for more emerging enterprises to achieve better development", continue to provide unwavering assistance to exceptional fund managers and entrepreneurs, actively promote industrial upgrading and structural optimization, and inject momentum into the development of emerging industries.